Not logged inChallenges and Potential Solutions to Advance Global Cancer Drug Development
Glasmacher, Axel; Lyerly, Kim; Wolf, Birgit; Zapella, Pio; Zielinska, Lidia; Clark, Emma; Mauer, Murielle; Paiva, Bruno; Schiel, Anja; Sweeney, Fergus; Uyl-de Groot, Carin A.; Von Lilienfeld-Toal, Marie; Verweij, Jaap .png)
Share.png)
SaveEvaluating the statistical utility and information loss in the transformation of a real-world oncology database from CDISC-SDTM to OMOP-CDMLambert, A.; Castagne, C.; Pau, D.; Chmiel, J.; Labarga, A.; Boernert, E.; Margraff, F.; Bachot, C.; Kaczmarek, L.; Toshev, D.; Martinez, J.; Stone, T. Share Save Evaluation of Current Statistical Methods for Implementing Quality Tolerance LimitsKilaru, Rakhi; Amodio, Sonia; Li, Yasha; Zeng, Yuling; Khaplonov, Arseny; Wang, Zhongkai; Wells, Christine; Love, Sharon; Rolfe, Tim; Talbot, Susan Share Save Quantitative relationship between tominersen concentrations in cerebrospinal fluid and biomarker changes in Huntington's disease patientsYamamoto, Yumi; Silber Baumann, Hanna E.; Bjornsson, Marcus; Grimsey, Paul; Hawellek, David J.; Anderson, Karen; Leavitt, Blair R.; Landwehrmeyer, Bernhard G.; Tabrizi, Sarah; Mccolgan, Peter; Wild, Edward J.; Sanwald Ducray, Patricia Share Save Share Save Effects of obinutuzumab on urinary renal biomarkers in lupus nephritis: a post hoc exploratory analysis of the phase II nobility studyVilet, Juan Manuel Mejia; Clarke, Holly J.; Lanza, Ben; Anania, Veronica; Pendergraft, William F.; Omachi, Theodore A.; Parodis, Ioannis; Jones, Rachel B.; Lightstone, Liz; Rovin, Brad; Raghu, Harini Share Save Share Save Share Save A Phase 2b, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease (PADOVA): Rationale, design, and baseline dataNikolcheva, Tania; Pagano, Gennaro; Pross, Nathalie; Simuni, Tanya; Marek, Kenneth; Postuma, Ronald B.; Pavese, Nicola; Stocchi, Fabrizio; Seppi, Klaus; Monnet, Annabelle; Shariati, Nima; Ricci, Benedicte; Rutten-Jacobs, Loes; Respondek, Gesine; Kustermann, Thomas; Taylor, Kirsten I.; Trundell, Dylan; Fontoura, Paulo; Doody, Rachelle; Svoboda, Hanno; Bonni, Azad; Prasinezumab Study Grp Share Save CANBERRA: A Phase II Randomized Clinical Trial to Test the Therapeutic Potential of Oral Vicasinabin in Diabetic RetinopathyArmendariz, Beatriz G.; Luhman, Ulrich F. O.; Berger, Brian; Hernandez-Sanchez, Jules; Bogman, Katrijn; Mitrousis, Nikolaos; Wollenhaupt, Martina; Kent, David; Wenzel, Andreas; Fauser, Sascha Share Save Estimation of and clinical consensus on the meaningful motor progression threshold on MDS-UPDRS Part IIITrundell, Dylan; Davies, Evan W.; Barrett, Louise; Zanigni, Stefano; Shariati, Nima; Rogers, Rebecca; Monnet, Annabelle; Moore, Emma; Pross, Nathalie; Pagano, Gennaro; Cano, Stefan; Nikolcheva, Tania Share Save Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapyPotter, Rachael A.; Moeller, Ida H.; Khan, Sohrab; Haegel, Helene; Hollenstein, Andreas; Steiner, Guido; Wandel, Christoph; Murphy, Alexander P.; Asher, Damon R.; Palatinsky, Emanuel; Griffin, Danielle A.; Mason, Stefanie; Iannaccone, Susan T.; Zaidman, Craig M.; Rodino-Klapac, Louise R. Share Save Share Save Efficacy, durability and safety of faricimab for patients with neovascular age-related macular degeneration: 48-week results from the phase 3 LUCERNE China subpopulationZou, Wenjun; Jiang, Qin; Wang, Yanling; Wei, Wenbin; Sun, Xiaodong; Basu, Karen; Chen, Qiuyu; Kotecha, Aachal; Li, Sijing; Liu, Ruyuan; Patel, Vaibhavi; Chen, Youxin Share Save Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I studyNewsome, Scott D.; Goldstick, Lawrence; Robertson, Derrick S.; Bowen, James D.; Naismith, Robert T.; Townsend, Ben; Figueiredo, Catarina; Kletzl, Heidemarie; Giraudon, Mylene; Bortolami, Oscar; Zecevic, Dusanka; Giacobino, Caroline; Clinch, Susanne; Shen, Yun-An; Deol-Bhullar, Gurpreet; Bermel, Robert A. Share Save Share Save Evaluation of Machine Learning to Detect Influenza UsingWearable Sensor Data and Patient-Reported Symptoms:Cohort StudyFarooq, Kamran; Lim, Melody; Dennison-Hal, Lawrence; Janson, Finn; Olszewska, Aspen Hazel; Zabidi, Muhammad Mamduh Ahmad; Haratym-Rojek, Anna; Narowski, Karol; Clinch, Barry; Prunotto, Marco; Chawla, Devika; Hunter, Victoria; Ukachukwu, Vincent Share Save Points to consider when initiating clinical investigations in autistic paediatric populations-A White PaperHam, Lindsay M.; Staunton, Hannah; Schulz, Jan Michael; Tillmann, Julian; Volz, Dietmar; Murtagh, Lorraine; Chatham, Christopher; Chamberlain, Stormy; Schoenenberger, Philipp; Pandina, Gahan; Wang, Paul; Kas, Martien J. H.; Arango, Celso; Murphy, Declan Share Save Alectinib Versus Crizotinib in Asian Patients With Treatment-Naïve Advanced ALK-Positive NSCLC : Five-Year Update From the Phase 3 ALESIA StudyZhou, Caicun; Lu, You; Kim, Sang-We; Reungwetwattana, Thanyanan; Zhou, Jianying; Zhang, Yiping; He, Jianxing; Yang, Jin-Ji; Cheng, Ying; Lee, Se-Hoon; Chang, Jianhua; Fang, Jian; Liu, Zhe; Bu, Lilian; Qian, Li; Xu, Tingting; Archer, Venice; Hilton, Magalie; Zhou, Mingzhu; Zhang, Li Share Save Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD)Neve, Anuja; Das, Bibha; Wojtowicz, Jakub; Huang, Zhiyue; Bullain, Szofia; Watkin, Michelle; Lott, Dominik; Bittner, Tobias; Delmar, Paul; Klein, Gregory; Hofmann, Carsten; Kerchner, Geoffrey A.; Smith, Janice; Baudler, Monika; Fontoura, Paulo; Doody, Rachelle S. Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
